✦ LIBER ✦

Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias

✍ Scribed by Shah, Neil P; Sawyers, Charles L

Book ID: 110068028
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 191 KB
Volume: 22
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1206942

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular and chromosomal mechanisms of

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy

✍ Hochhaus, A; Kreil, S; Corbin, A S; La Rosée, P; Müller, M C; Lahaye, T; Hanfste 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 177 KB

Resistance of Philadelphia-chromosome po

Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back

✍ Bubnoff, N von; Peschel, C; Duyster, J 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 315 KB

Reversal of the resistance to STI571 in

Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells

✍ Motoi Mukai; Xiao-Fang Che; Tatsuhiko Furukawa; Tomoyuki Sumizawa; Shunji Aoki; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

Changes associated with the development

Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein

✍ Barbara Scappini; Simona Gatto; Francesco Onida; Clara Ricci; Vladimir Divoky; W 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 1 views

## Abstract ## BACKGROUND Although various mechanisms have been recognized as being associated with the development of resistance to imatinib mesylate in vitro and in clinical situations, their relative significance and contributions remain poorly understood, as is the sequence of events leading t

Tyrosine kinase inhibitor STI571 in the

Tyrosine kinase inhibitor STI571 in the treatment of Philadelphia chromosome-positive leukaemia failing myeloablative stem cell transplantation

✍ Au, W Y; Lie, A K W; Ma, S K; Wan, T S; Liang, R; Chan, E C; Kwong, Y L 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 102 KB

In vitro effects of STI 571-containing d

In vitro effects of STI 571-containing drug combinations on the growth of Philadelphia-positive chronic myelogenous leukemia cells

✍ Barbara Scappini; Francesco Onida; Hagop M. Kantarjian; Li Dong; Srdan Verstovse 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 607 KB

## Abstract ## BACKGROUND Chronic myelogenous leukemia (CML) is characterized by a molecular aberration, a fusion __BCR‐ABL__ gene encoding for aberrant tyrosine kinase activity, which is crucial in the pathogenesis of CML. In vitro, inhibition of BCR‐ABL protein tyrosine kinase activity by a tyro